HIV Citations List: October 2024

Literature Citations

1. Molecular Design and Evaluation of Aza-Polycyclic Carbamoyl Pyridones as HIV-1 Integrase Strand Transfer Inhibitors. Akiyama, T., B.A. Johns, Y. Taoda, H. Yoshida, T. Taishi, T. Kawasuji, H. Murai, T. Yoshinaga, A. Sato, T. Seki, M. Koyama, S. Miki, S. Kawauchi-Miki, A. Kagitani-Suyama, and T. Fujiwara. Bioorganic & Medicinal Chemistry Letters, 2024. 111: p. 129902. PMID[39059564].
[PubMed]. HIV_10_2024.

2. Synthesis, Structural Characterization, Computational Studies, and in Silico and in Vitro Biological Activities of Cyclodextrin Inclusion Complex with Sulfonamide Derived from L-Valine as Antimicrobial and Anti-HIV-1 Agents. Attou, Z., Y. Abdi, Y. Arbia, B. Bezzina, H. Merazka, M. Mohamdi, D. Siziani, M. Brahimi, and N. Bensouilah. Structural Chemistry, 2024. ISI[001340296300001]
[WOS]. HIV_10_2024.

3. Mechanism of Action of a Viral-Derived and Proteolysis-Resistant HIV-1 Inhibitor Peptide Targeting the Chemokine Receptor CXCR4. Cadima-Couto, I., A. Tauzin, J.M. Freire, T.N. Figueira, R. Silva, C. Perez-Peinado, C. Cunha-Santos, I. Bartolo, N. Taveira, L. Gano, J.D.G. Correia, J. Gonçalves, F. Mammano, D. Andreu, M. Castanho, and A.S. Veiga. Journal of Peptide Science, 2024. 30. ISI[001314146400062].
[WOS]. HIV_10_2024.

4. Advances in the Synthesis of (3R,3aS,6aR)-Hexahydrofuro- 2,3-B Furan-3-Ol , a Key Ligand of the HIV Protease Inhibitors. Dong, M.Q., D.W. Teng, and G.R. Cao. Chemistry of Heterocyclic Compounds, 2024. ISI[001326687700002].
[WOS]. HIV_10_2024.

5. Inhibition of HIV-1 Infection with Curcumin Conjugated Peg-Citrate Dendrimer; a New Nano Formulation. Ebrahimi, S., M. Sadeghizadeh, M.R. Aghasadeghi, M.S. Ardestani, S.A. Amini, and R. Vahabpour. BMC Complementary Medicine and Therapies, 2024. 24(1): p. 350. PMID[39358802]. PMCID[PMC11448447].
[PubMed]. HIV_10_2024.

6. The 3D-QSAR Study, Molecular Docking, and ADMET Analysis of Darunavir Derivatives of HIV-1 Protease Inhibitors. Fang, R.J., Y.J. Zhang, W.X. Wang, T.L. Wu, S.J. Zhang, Y.Y. He, F. Xiong, and Z.H. Wang. Letters in Drug Design & Discovery, 2024. 21(13): p. 2590-2603. ISI[001326854300017].
[WOS]. HIV_10_2024.

7. Daily Variations of CD4+T-Cell Counts and Phenotype in Relationship with Residual Viral Transcription in the Blood of People with HIV-1 Receiving Antiretroviral Therapy. Fert, A., D. Chatterjee, T.R.W. Salinas, Y. Zhang, D. Planas, A. Cattin, L.R. Marchand, E.M. Gabriel, C.D. Ngassaki-Yoka, J. Girouard, A. Filali-Mouhim, N. Cermakian, D.E. Kaufmann, J.P. Routy, and P. Ancuta. Journal of the International Aids Society, 2024. 27: p. 8-8. ISI[001311241400018].
[WOS]. HIV_10_2024.

8. Novel Prodrugs of HIV-1 Protease Inhibitor with an N-Amidinoglycine Moiety. Hamada, Y. and K. Usui. Journal of Peptide Science, 2024. 30. ISI[001314146400673].
[WOS]. HIV_10_2024.

9. Symmetrical Phosphinic Acids: Synthesis and Esterification Optimization toward Potential HIV Prodrugs. Hayat, K., G. Nixon, Q. Zhang, and M. Matziari. ACS Omega, 2024. 9(40): p. 41742-41757. PMID[39398174]. PMCID[PMC11465283].
[PubMed]. HIV_10_2024.

10. Isotretinoin Promotes Elimination of Translation-Competent HIV Latent Reservoirs in CD4T Cells. Howard, J.N., C. Levinger, S. Deletsu, R. Fromentin, N. Chomont, and A. Bosque. PLOS Pathogens, 2024. 20(10): p. e1012601. PMID[39401241]. PMCID[PMC11501018].
[PubMed]. HIV_10_2024.

11. A cGAS-Mediated Type I Interferon Response in Human CD4+ T Cells Depends on Productive Infection and Is Conserved over HIV Types and Strains. Janevska, M., T. Cammaert, E. Naessens, and B. Verhasselt. Journal of Virology, 2024. 98(10): p. e0087724. PMID[39269176]. PMCID[PMC11494880].
[PubMed]. HIV_10_2024.

12. Artificial Antigen-Presenting Cell System Reveals CD28's Role in Modulating T cell Functions During Human Immunodeficiency Virus Infection. Kabakibo, T.S., E. Arnold, K. Padhan, A. Lemieux, G.G. Ortega-Delgado, J.P. Routy, N. Shoukry, M. Dubé, and D.E. Kaufmann. iScience, 2024. 27(10): p. 110947. PMID[39381752]. PMCID[PMC11460474].
[PubMed]. HIV_10_2024.

13. Mannosylated Pamam G2 Dendrimers Mediated Rate Programmed Delivery of Efavirenz Target HIV Viral Latency at Reservoirs. Kharwade, R., M. Kazi, N. Mahajan, P. Badole, S. More, A. Kayali, M. Noushad Javed, and M. Kaleem. Saudi Pharmaceutical Journal, 2024. 32(10): p. 102154. PMID[39282004]. PMCID[PMC11399684].
[PubMed]. HIV_10_2024.

14. Efficacy of Integrase Strand Transfer Inhibitors and the Capsid Inhibitor Lenacapavir against HIV-2, and Exploring the Effect of Raltegravir on the Activity of SARS-CoV-2. Kiarie, I.W., G. Hoffka, M. Laporte, P. Leyssen, J. Neyts, J. Tőzsér, and M. Mahdi. Viruses, 2024. 16(10). PMID[39459940]. PMCID[PMC11512360].
[PubMed]. HIV_10_2024.

15. Discovery of L15 as a Novel Vif PROTAC Degrader with Antiviral Activity against HIV-1. Luo, D., R. Luo, W. Wang, R. Deng, S. Wang, X. Ma, C. Pu, Y. Liu, H. Zhang, S. Yu, Q. Huang, L. Yang, Y. Tong, Y. Zheng, and R. Li. Bioorganic & Medicinal Chemistry Letters, 2024. 111: p. 129880. PMID[38996941].
[PubMed]. HIV_10_2024.

16. The Combination of Three CD4-Induced Antibodies Targeting Highly Conserved Env Regions with a Small CD4-Mimetic Achieves Potent ADCC Activity. Marchitto, L., J. Richard, J. Prévost, A. Tauzin, D. Yang, T.J. Chiu, H.C. Chen, M.A. Díaz-Salinas, M. Nayrac, M. Benlarbi, G. Beaudoin-Bussières, S.P. Anand, K. Dionne, É. Bélanger, D. Chatterjee, H. Medjahed, C. Bourassa, W.D. Tolbert, B.H. Hahn, J.B. Munro, M. Pazgier, A.B. Smith, 3rd, and A. Finzi. Journal of Virology, 2024. 98(10): p. e0101624. PMID[39248460]. PMCID[PMC11495009].
[PubMed]. HIV_10_2024.

17. Development of Antibody Drug Conjugates as HIV Entry Inhibitors. Miura, Y., K. Tsuji, T. Kobayakawa, K. Matsumoto, T. Kuwata, S. Matsushita, and H. Tamamura. Journal of Peptide Science, 2024. 30. ISI[001314146400255].
[WOS]. HIV_10_2024.

18. Conjugation of Anti-HIV gp41 Monoclonal Antibody to a Drug Capable of Targeting Resting Lymphocytes Produces an Effective Cytotoxic Anti-HIV Immunoconjugate. Pincus, S.H., F.M. Cole, K. Ober, M. Tokmina-Lukaszewska, T. Marcotte, E.W. Kovacs, T. Zhu, A. Khasanov, V. Copié, and T. Peters. Journal of Virology, 2024. 98(10): p. e0064724. PMID[39283123]. PMCID[PMC11494876].
[PubMed]. HIV_10_2024.

19. HIV-1 Vpr-Induced DNA Damage Activates NF-kB through ATM-NEMO Independent of Cell Cycle Arrest. Sandoval, C., K. Nisson, and O.I. Fregoso. mBio, 2024. 15(10): p. e0024024. PMID[39269169]. PMCID[PMC11481869].
[PubMed]. HIV_10_2024.

20. Discovery of New Acetamide Derivatives of 5-Indole-1,3,4-Oxadiazol-2-Thiol as Inhibitors of HIV-1 Tat-Mediated Viral Transcription. Shin, Y., C.M. Park, D.E. Kim, S. Kim, S.Y. Lee, J.Y. Lee, W.H. Jeon, H.G. Kim, S. Bae, and C.H. Yoon. Antimicrobial Agents and Chemotherapy, 2024. 68(10): p. e0064324. PMID[39230310]. PMCID[PMC11459959].
[PubMed]. HIV_10_2024.

21. Quantum Mechanical Analysis of Newly Synthesized HIV-1 Protease Inhibitors: Evaluation of Wild-Type and Resistant Strain Binding Interactions. Silva, G.V.R., K.A. Ramos Reiniger, G. de Lima Menezes, K.S. Bezerra, D.S. Galvão, M.V. Saivish, R.A. da Silva, S. Akash, J.Z. Tayyeb, J.I.N. Oliveira, and U.L. Fulco. Physical Chemistry Chemical Physics, 2024. 26(42): p. 26748-26764. PMID[39402950].
[PubMed]. HIV_10_2024.

22. Comprehensive Database of HIV Mutations Selected During Antiretroviral in Vitro Passage Experiments. Tao, K., J. Zhou, P. Nagarajan, P.L. Tzou, and R.W. Shafer. Antiviral Research, 2024. 230: p. 105988. PMID[39154752]. PMCID[PMC11412686].
[PubMed]. HIV_10_2024.

23. Inhibition of HIV-1 Replication by Nanobodies Targeting Tetraspanin CD9. Umotoy, J.C., P.Z. Kroon, S. Man, K.A. van Dort, T. Atabey, A.I. Schriek, G. Dekkers, E. Herrera-Carrillo, T.B.H. Geijtenbeek, R. Heukers, N.A. Kootstra, M.J. van Gils, and S.W. de Taeye. iScience, 2024. 27(10): p. 110958. PMID[39391729]. PMCID[PMC11465043].
[PubMed]. HIV_10_2024.

24. Design, Synthesis, and Biological Evaluation of Darunavir Analogs as HIV-1 Protease Inhibitors. Ur Rehman, M.A., H. Chuntakaruk, S. Amphan, A. Suroengrit, K. Hengphasatporn, Y. Shigeta, T. Rungrotmongkol, K. Krusong, S. Boonyasuppayakorn, C. Aonbangkhen, and T. Khotavivattana. ACS Bio & Med Chem Au, 2024. 4(5): p. 242-256. PMID[39431267]. PMCID[PMC11487539].
[PubMed]. HIV_10_2024.

25. The Avengers: SAMHD1 Cooperates with MX2/MxB to Defend against HIV-1. Wan, Z., G. Zhong, and H. Wang. mBio, 2024. 15(10): p. e0167524. PMID[39240132]. PMCID[PMC11481905].
[PubMed]. HIV_10_2024.

26. Tsg101 UEV Interaction with Nedd4 HECT Relieves E3 Ligase Auto-Inhibition, Promoting HIV-1 Assembly and CA-SP1 Maturation Cleavage. Watanabe, S.M., D.A. Nyenhuis, M. Khan, L.S. Ehrlich, I. Ischenko, M.D. Powell, N. Tjandra, and C.A. Carter. Viruses, 2024. 16(10). PMID[39459900]. PMCID[PMC11512315].
[PubMed]. HIV_10_2024.

27. HIV-1 Vpu Induces Neurotoxicity by Promoting Caspase 3-Dependent Cleavage of TDP-43. Yang, J., Y. Li, H. Li, H. Zhang, H. Guo, X. Zheng, X.F. Yu, and W. Wei. EMBO Reports, 2024. 25(10): p. 4337-4357. PMID[39242776]. PMCID[PMC11467202].
[PubMed]. HIV_10_2024.

28. Molecular Docking Studies of Synthesized Pyridazinone Scaffolds as Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs). Yusuf, M., O. Abdulaziz, A. Aljuaid, M. Allahyani, M. Almehmadi, A.Y.A. Alzahrani, S. Verma, and M. Asif. Polycyclic Aromatic Compounds, 2024. ISI[001335801000001].
[WOS]. HIV_10_2024.

29. HIV-Induced RSAD2/Viperin Supports Sustained Infection of Monocyte-Derived Macrophages. Zankharia, U., Y. Yi, F. Lu, O. Vladimirova, B.C. Karisetty, J. Wikramasinghe, A. Kossenkov, R.G. Collman, and P.M. Lieberman. Journal of Virology, 2024. 98(10): p. e0086324. PMID[39258908]. PMCID[PMC11494996].
[PubMed]. HIV_10_2024.

30. Conformations of Membrane Human Immunodeficiency Virus (HIV-1) Envelope Glycoproteins Solubilized in Amphipol A18 Lipid-Nanodiscs. Zhang, S., S. Anang, Z. Zhang, H.T. Nguyen, H. Ding, J.C. Kappes, and J. Sodroski. Journal of Virology, 2024. 98(10): p. e0063124. PMID[39248459]. PMCID[PMC11495050].
[PubMed]. HIV_10_2024.

31. Efficient Synthesis of Three-Helix Bundle Proteins Using Ligase-Mediated Trimerization of HIV-1 Fusion Inhibitor T20 on a Dendrimer Scaffold. Zhang, X.H., Y.Y. Xia, C.F. Liu, and J.P. Tam. Journal of Peptide Science, 2024. 30. ISI[001314146400638].
[WOS]. HIV_10_2024.

Patent Citations

This month, no relevant HIV patents were identified.